Valiance Clinical Research
Tarzana, California 91356-6695
4 studies enrolling now · 14 studies all time
What they study most
Atherosclerotic Cardiovascular Disease (ASCVD), Blood Pressure Disorders, COVID-19, Cardiovascular Diseases, Chronic Kidney Disease (CKD), Diabetic Kidney Disease (DKD), End Stage Kidney Disease, Heart Failure, Hypertension, Moderate Alzheimer Disease, Obesity, Overweight
Studies at this site
- Study to Assess the Effects of Angiopoietin-like Protein 3 (ANGPTL3) Inhibition in Adult Participants With Diabetic Kidney Disease — Recruiting now
- Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD) — Recruiting now
- A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity — Recruiting now
- Clinical Study of SNK01 in Participants With Moderate Alzheimer's Disease — Recruiting now
- A Study of SNP-ACTH (1-39) Gel in Patients With Primary Membranous Nephropathy — Recruiting now
- A Study to Test if Trevogrumab or Trevogrumab With Garetosmab When Taken With Semaglutide is Safe and How Well They Work in Adult Patients With Obesity for Weight Loss, Fat Loss, and Lean Mass Preservation — Running, not enrolling
- The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes) — Running, not enrolling
- A Study of Tirzepatide (LY3298176) on the Reduction on Morbidity and Mortality in Adults With Obesity — Running, not enrolling
- Efficacy and Safety of GMRx2 Compared to Dual Combinations for the Treatment of Hypertension — Completed
- Efficacy and Safety of GMRx2 Compared to Placebo for the Treatment of Hypertension — Completed
- Phase 2a to Evaluate PL-8177 in Subjects with Active Ulcerative Colitis (UC) — Running, not enrolling
- PBI-0451 (Pomotrelvir) Phase 2 Study in Nonhospitalized Symptomatic Adults With COVID-19 — Stopped early
- Effect of Korean Red Ginseng Extract on Blood Flow in Healthy Adults — Completed
- The Efficacy and Safety of Cobitolimod in Participants With Moderate to Severe Active Left-Sided Ulcerative Colitis — Stopped early